ab103477 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab103477 は 6 報の論文で使用されています。

  • Li G  et al. C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance. Cell Mol Biol Lett 23:6 (2018). WB . PubMed: 29483928
  • Zhu H  et al. In vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-?B signaling pathway. Exp Ther Med 15:2643-2648 (2018). PubMed: 29456667
  • Chen Y  et al. Genomic analysis of drug resistant small cell lung cancer cell lines by combining mRNA and miRNA expression profiling. Oncol Lett 13:4077-4084 (2017). PubMed: 28599409
  • Shi L  et al. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J. BMC Cancer 17:138 (2017). WB . PubMed: 28202053
  • Zhao H  et al. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol 46:893-902 (2016). PubMed: 27432453
  • Liu Z  et al. Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells. Oncol Lett 12:3944-3948 (2016). WB ; Human . PubMed: 27895754

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録